Published February 1988 | Version v1
Journal article

Radioimmunoscintigraphic localization of inflammatory lesions. Pt. 3

  • 1. Kantonsspital Aarau (Switzerland). Nuklearmedizinische Abt.
  • 2. Eidgenoessisches Inst. fuer Reaktorforschung, Wuerenlingen (Switzerland)

Description

Five patients with inflammatory lesions received anti granulocytes murine monoclonal antibody (Mabgc) infused over 5 to 15 min at doses between 3.4 and 5.4 mCi 123I (120 μg antibody). Clearance of 123I from blood pool closely fits a biexponential mathematical model with the two effective half lives 0.77 h and 31.5 h. The spontaneous release of 123I was found to be relatively low in the blood pool. The cumulative urinary excretion of the 123I label over 120 h was in the range of 63% of the totally administered dose and is assumed to represent only a low molecular compound or 123I alone as iodide. Analysis of the label in spleen, liver and red marrow showed that the concentration of label in these tissues remains more or less constant over a period of 20 h after infusion. With data of liver, spleen, red marrow and whole body activity over a period of 24 h, an estimated radiation dose was calculated. Compared with 111In labelled leucocytes, especially in spleen, the absorbed dose is lower by factor of ten per examination. (orig.)

Additional details

Additional titles

Subtitle (English)
Pharmacokinetics and estimated absorbed radiation dose in man

Publishing Information

Journal Title
Eur. J. Nucl. Med.
Journal Volume
13
Journal Issue
11
Series
Eur. J. Nucl. Med.
Journal Page Range
594-597
ISSN
0340-6997
CODEN
EJNMD